FDA Inspection 1297066 — John B. Buse, M.D., Ph.D.
The FDA completed an inspection of John B. Buse, M.D., Ph.D. on Dec 18, 2025 in Chapel Hill, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 18, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chapel Hill, NC (United States)
Additional Details
Clinical Investigator (CI)